We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Laboratory Releases Enhanced Microarray for Prenatal Diagnosis

By LabMedica International staff writers
Posted on 13 Nov 2008
An enhanced microarray enables prenatal detection of chromosome abnormalities that result in missing or extra pieces of DNA.

The enhanced PrenatalChip targets over 100 discrete chromosomal regions, the gain or loss of which results in a genetic disorder, while minimizing coverage of regions of unknown clinical significance. More...
If more coverage is required, the whole-genome microarray is available--especially in cases with abnormal findings by ultrasound.

The enhanced PrenatalChip is the first level of Signature Genomic laboratories' (Spokane, WA, USA) prenatal service. "Pregnancy can be a time of great anxiety, particularly if a genetic disorder is suspected,” said Justine Coppinger, certified genetic counselor at Signature. "We approach prenatal diagnosis responsibly, balancing timely, comprehensive diagnoses with the desire to minimize anxiety over unclear results. We encourage physicians to discuss the most appropriate test for their patients with our certified genetic counselors.”

Signature Genomic Laboratories was the first laboratory to provide microarray-based cytogenetic diagnostics with its proprietary SignatureChip and is a supplier of microarray-based chromosome analysis. Signature's worldwide clients include clinical geneticists, neurologists, pediatricians, neonatologists, obstetricians, and the research community.

Related Links:
Signature Genomics



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.